Yarbrough Capital’s Johnson & Johnson JNJ Stock Holding History

Yarbrough Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,538	Closed	-$249K	–	201
2024 Q3	$249K	Hold	1,538	–	–	0.01%	192
2024 Q2	$225K	Hold	1,538	–	–	0.01%	190
2024 Q1	$243K	Hold	1,538	–	–	0.01%	190
2023 Q4	$241K	Hold	1,538	–	–	0.01%	191
2023 Q3	$240K	Hold	1,538	–	–	0.01%	195
2023 Q2	$255K	Sell	1,538 -1,962	-56%	-$317K	0.01%	187
2023 Q1	$543K	Hold	3,500	–	–	0.04%	122
2022 Q4	$618K	Hold	3,500	–	–	0.05%	93
2022 Q3	$572K	Hold	3,500	–	–	0.05%	101
2022 Q2	$621K	Hold	3,500	–	–	0.05%	98
2022 Q1	$620K	Hold	3,500	–	–	0.04%	120
2021 Q4	$599K	Buy	+3,500	New	+$573K	0.03%	130

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Yarbrough Capital's JNJ Position: Q4 2024 in Review

Yarbrough Capital sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 1,538 shares — an estimated $249K sold.

Yarbrough Capital first reported a position in JNJ in Q4 2021 and held it in 12 quarters. The position peaked at $621K in Q2 2022. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

Yarbrough Capital reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
Yarbrough Capital sold 1,538 Johnson & Johnson shares in Q4 2024, an estimated $249K.
Yarbrough Capital first reported a position in Johnson & Johnson in Q4 2021 and held it in 12 quarters.
Yarbrough Capital's Johnson & Johnson position peaked at $621K in Q2 2022.
4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Yarbrough Capital's 13F filing for Q4 2024, filed 15 Jan 2025.